grant
Validating airway mRNA delivery for neoantigen presentation
Organization UKRILocation United Kingdom
UKRIUK ResearchGrantActive
Description preview
Each year in the UK, more than 49,000 people are diagnosed with lung cancer and around a quarter contain mutations in the KRAS gene. Once considered 'undruggable', KRAS can now be targeted by advanced therapeutic approaches such as mRNA based personalised vaccines that can train the immune system to recognise mutated proteins (neoantigens) and…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click